Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
BMC Gastroenterology|October 13, 2020
Massive iron overload and acute-on-chronic liver failure in a patient with Diamond-Blackfan anaemia: a case reportGuilherme Rossi Assis-Mendonça, Marlone Cunha-Silva, Mariana Franson Fernandes, et al.
Therapeutic Advances in Gastroenterology|February 4, 2022
Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL studyCarlos Taxonera, María Pilar Martínez-Montiel, Manuel Barreiro-de-Acosta, et al.
Cancers|July 29, 2023
Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant MelanomaMaría Belén García-Ortega, Ernesto Aparicio, Carmen Griñán-Lisón, et al.
The American Journal of Case Reports|June 29, 2022
Acute Hepatitis with Positive Autoantibodies: A Case of Natalizumab-Induced Early-Onset Liver InjuryMarlone Cunha-Silva, Priscilla Brito Sena de Moraes, Pedro Rodrigues de Carvalho, et al.
Digestive Diseases and Sciences|December 21, 2016
Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose EscalationCarlos Taxonera, Eva Iglesias, Fernando Muñoz, et al.
Inflammatory Bowel Diseases|July 4, 2017
Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative ColitisCarlos Taxonera, Cristina Rodríguez, Federico Bertoletti, et al.
Digestive Diseases and Sciences|June 6, 2015
Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative ColitisCarlos Taxonera, Manuel Barreiro-de Acosta, Marta Calvo, et al.
Scientific Reports|October 21, 2020
Real-life experience with 4 years of golimumab persistence in ulcerative colitis patientsMarisa Iborra, Natalia García-Morales, Saoia Rubio, et al.
Journal of Crohn'S & Colitis|January 21, 2016
Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's DiseaseCarlos Taxonera, Manuel Barreiro-de-Acosta, Guillermo Bastida, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 5, 2019
Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trialCarlos Taxonera, Antonio López-Sanromán, Isabel Vera-Mendoza, et al.
Pageof 7